This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Bingjie Ren
Introduction
Bingjie Ren is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have potential therapeutic applications.
Latest Patents
Bingjie Ren holds a patent for a crystal form and a salt type of a substituted 2-hydro-pyrazole derivative. This invention includes a preparation method for the compound and its use in the development of medicaments aimed at treating various cancers, including breast cancer and lung cancer. His innovative work in this area highlights the importance of chemical derivatives in modern medicine.
Career Highlights
Ren is associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving cancer treatment options through innovative chemical solutions.
Collaborations
Bingjie Ren has collaborated with esteemed colleagues such as Charles Z Ding and Shuhui Chen. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Bingjie Ren's contributions to medicinal chemistry and his innovative patent demonstrate his dedication to advancing cancer treatment. His work not only reflects his expertise but also the collaborative spirit of the scientific community.